2024. Prostate-specific Membrane Antigen (PSMA): A Diagnostic and Therapeutic Target in Advanced Prostate Cancer. Canadian Oncology Today. 1, 3 (Oct. 2024), 10–16. DOI:https://doi.org/10.58931/cot.2024.1326.